Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hala Elnakat Thomas

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Oncotarget|March 28, 2018
Immune checkpoint inhibitors in large cell neuroendocrine carcinoma: current statusAman Chauhan, Susanne M Arnold, Jill Kolesar, et al.
RNA Biology|January 4, 2019
Balancing yield, purity and practicality: a modified differential ultracentrifugation protocol for efficient isolation of small extracellular vesicles from human serumScott M Langevin, Damaris Kuhnell, Melissa A Orr-Asman, et al.
Cell Reports|August 30, 2018
Mitochondrial Complex I Activity Is Required for Maximal AutophagyHala Elnakat Thomas, Yu Zhang, Jonathan A Stefely, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2018
Phenformin-Induced Mitochondrial Dysfunction Sensitizes Hepatocellular Carcinoma for Dual Inhibition of mTORSónia R Veiga, Xuemei Ge, Carol A Mercer, et al.
Cell Reports|March 2, 2017
Pharmacologic Targeting of S6K1 in PTEN-Deficient NeoplasiaHongqi Liu, Xizhi Feng, Kelli N Ennis, et al.
Autophagy|January 24, 2020
Mass spectrometry proteomics reveals a function for mammalian CALCOCO1 in MTOR-regulated selective autophagyJonathan A Stefely, Yu Zhang, Elyse C Freiberger, et al.
Targeted Oncology|March 31, 2017
A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid MalignanciesTrisha M Wise-Draper, Ganesh Moorthy, Mohamad A Salkeni, et al.
Science Translational Medicine|April 28, 2012
mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinomaHala Elnakat Thomas, Carol A Mercer, Larissa S Carnevalli, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Oncotarget|March 28, 2018
Immune checkpoint inhibitors in large cell neuroendocrine carcinoma: current statusAman Chauhan, Susanne M Arnold, Jill Kolesar, et al.
RNA Biology|January 4, 2019
Balancing yield, purity and practicality: a modified differential ultracentrifugation protocol for efficient isolation of small extracellular vesicles from human serumScott M Langevin, Damaris Kuhnell, Melissa A Orr-Asman, et al.
Cell Reports|August 30, 2018
Mitochondrial Complex I Activity Is Required for Maximal AutophagyHala Elnakat Thomas, Yu Zhang, Jonathan A Stefely, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2018
Phenformin-Induced Mitochondrial Dysfunction Sensitizes Hepatocellular Carcinoma for Dual Inhibition of mTORSónia R Veiga, Xuemei Ge, Carol A Mercer, et al.
Cell Reports|March 2, 2017
Pharmacologic Targeting of S6K1 in PTEN-Deficient NeoplasiaHongqi Liu, Xizhi Feng, Kelli N Ennis, et al.
Autophagy|January 24, 2020
Mass spectrometry proteomics reveals a function for mammalian CALCOCO1 in MTOR-regulated selective autophagyJonathan A Stefely, Yu Zhang, Elyse C Freiberger, et al.
Targeted Oncology|March 31, 2017
A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid MalignanciesTrisha M Wise-Draper, Ganesh Moorthy, Mohamad A Salkeni, et al.
Science Translational Medicine|April 28, 2012
mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinomaHala Elnakat Thomas, Carol A Mercer, Larissa S Carnevalli, et al.
Pageof 1